JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108327

Anti-APG5L/ATG5 antibody [EPR1755(2)]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

4

(7 Reviews)

|

(285 Publications)

Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) is a rabbit monoclonal antibody detecting APG5L/ATG5 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 190 publications

View Alternative Names

APG5L, ASP, ATG5, Autophagy protein 5, APG5-like, Apoptosis-specific protein

12 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Unpurified ab108327, at 1/100 dilution, staining APG5L/ATG5 in paraffin-embedded Human hepatocellular carcinoma tissue by Immunohistochemistry.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Unpurified ab108327, at 1/100 dilution, staining APG5L/ATG5 in paraffin-embedded Human ovarian adenocarcinoma tissue by Immunohistochemistry.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Immunohistochemical staining of paraffin embedded human cervical carcinoma with purified ab180327 at a working dilution of 1/150. The secondary antibody used is HRP goat anti-rabbit IgG H&L (ab97051) at 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.

Immunocytochemistry/ Immunofluorescence - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Immunofluorescence staining of MCF7 cells with purified ab108327 at a working dilution of 1/150, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 100% methanol and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab108327 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.

Immunoprecipitation - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • IP

Unknown

Immunoprecipitation - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

ab180327 (purified) at 1/20 immunoprecipitating CRSP8 in 10 μg PC-12 whole cell lysate (Lanes 1 and 2, observed at 55 kDa). Lane 3 - PBS. For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1500 dilution. Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST

All lanes:

Immunoprecipitation - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327)

Predicted band size: 32 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

False colour image of Western blot : Anti-APG5L/ATG5 antibody [EPR1755(2)] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab108327 was shown to bind specifically to APG5L/ATG5. A band was observed at 50 kDa in wild-type THP-1 cell lysates with no signal observed at this size in ATG5 knockout cell line ab277835 (knockout cell lysate ab290722). To generate this image, wild-type and ATG5 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/1000 dilution

Lane 1:

Wild-type THP-1 cell lysate at 20 µg

Lane 2:

ATG5 knockout THP-1 cell lysate at 20 µg

Lane 3:

U-87 MG cell lysate at 20 µg

Lane 4:

HeLa cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 50 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/10000 dilution

All lanes:

Raji cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/10000 dilution

Predicted band size: 32 kDa

Observed band size: 55 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : APG5L/ATG5 knockout HAP1 cell lysate (20 μg)
Lane 3 : Raji cell lysate (20 μg)
Lane 4 : Jeg-3 cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab108327 observed at 52 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab108327 was shown to specifically react with APG5L/ATG5 when APG5L/ATG5 knockout samples were used. Wild-type and APG5L/ATG5 knockout samples were subjected to SDS-PAGE. ab108327 and ab8245 (loading control to GAPDH) were both diluted 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327)

Predicted band size: 32 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Unknown

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Secondary antibody - anti-rabbit HRP (ab6721)

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/1000 dilution

Lane 1:

Raji cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

HT-1080 cell lysate at 10 µg

Lane 4:

Human fetal kidney cell lysate at 10 µg

Lane 5:

C6 cell lysate at 10 µg

Lane 6:

Raw264.7 cell lysate at 10 µg

Lane 7:

PC-12 cell lysate at 10 µg

Lane 8:

NIH3T3 cell lysate at 10 µg

Predicted band size: 32 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/2000 dilution

All lanes:

human fetal kidney at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 102 kDa,32 kDa

Observed band size: 32 kDa,55 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/2000 dilution

All lanes:

HT-1080 cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 32 kDa

Observed band size: 55 kDa

false

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)
  • WB

Lab

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (AB108327)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) at 1/10000 dilution

Lane 1:

C6 cell lysate at 20 µg

Lane 2:

PC-12 cell lysate at 20 µg

Lane 3:

NIH/3T3 cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 32 kDa

Observed band size: 55 kDa

false

  • Carrier free

    Anti-APG5L/ATG5 antibody [EPR1755(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR1755(2)

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

ICC/IF, WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p>Antigen retrieval is recommended.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of APG5L/ATG5?
Anti-APG5L/ATG5 [EPR1755(2)] (ab108327) specifically detects a band for APG5L/ATG5 (UniProt: Q9H1Y0) at a molecular weight of 32kDa.

Trusted by the scientific community
Anti-APG5L/ATG5 [EPR1755(2)] (ab108327) was first used in a scientific publication in 2012 and has been cited over 190 times in peer-reviewed journals.

Reviewed by scientists
Anti-APG5L/ATG5 [EPR1755(2)] (ab108327) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-APG5L/ATG5 antibody [EPR1755(2)] (ab108327) has been confirmed by Western blot testing in ATG5 Knockout HAP1 cell line, ab277835.

Other related products
We have a range of other formats of antibody clone [EPR1755(2)] also available for your convenience: ab108327, HRP - ab199560, Carrier free - ab221604, ab307842, Carrier free - ab307843

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

APG5L commonly known as ATG5 or ATG5 protein plays a significant role in autophagy. This molecular component has a molecular weight of approximately 32 kDa. ATG5 is expressed in multiple tissue types with a higher expression profile in immune-related cells. The protein is essential for the formation of the autophagosome as it conjugates with ATG12 to form a complex that is critical for autophagosome membrane elongation.
Biological function summary

ATG5 plays an important part in the cellular process of autophagy affecting the degradation and recycling of cellular components. It is a part of a complex with ATG12 and ATG16L1 which facilitates the membrane building of the autophagosome. This protein is important for maintaining cellular homeostasis allowing the removal of damaged proteins and organelles and is involved in responses to stress and starvation.

Pathways

ATG5 is an important component in the autophagy pathway and is involved in cellular maintenance processes. This pathway is vital for the regulation of cell growth and metabolism. ATG5 works closely with other autophagy-related proteins such as LC3. The ATG5-ATG12 complex helps in the lipidation of LC3 which is critical for autophagosome maturation connecting its function to the mTOR signaling pathway that regulates many cellular processes.

Disruption in ATG5 function is linked to neurodegenerative diseases and cancer. For instance dysregulation of autophagy due to ATG5 dysfunction may result in the progression of neurodegenerative disorders like Alzheimer's disease. Additionally in certain cancers altered autophagy can influence the survival of cancer cells. The interplay between ATG5 and other proteins like p53 and Bcl-2 is under investigation to understand its role in these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is essential for its function. The ATG12-ATG5 conjugate acts as an E3-like enzyme which is required for lipidation of ATG8 family proteins and their association to the vesicle membranes. Involved in mitochondrial quality control after oxidative damage, and in subsequent cellular longevity. Plays a critical role in multiple aspects of lymphocyte development and is essential for both B and T lymphocyte survival and proliferation. Required for optimal processing and presentation of antigens for MHC II. Involved in the maintenance of axon morphology and membrane structures, as well as in normal adipocyte differentiation. Promotes primary ciliogenesis through removal of OFD1 from centriolar satellites and degradation of IFT20 via the autophagic pathway. As part of the ATG8 conjugation system with ATG12 and ATG16L1, required for recruitment of LRRK2 to stressed lysosomes and induction of LRRK2 kinase activity in response to lysosomal stress (By similarity).. May play an important role in the apoptotic process, possibly within the modified cytoskeleton. Its expression is a relatively late event in the apoptotic process, occurring downstream of caspase activity. Plays a crucial role in IFN-gamma-induced autophagic cell death by interacting with FADD.. (Microbial infection) May act as a proviral factor. In association with ATG12, negatively regulates the innate antiviral immune response by impairing the type I IFN production pathway upon vesicular stomatitis virus (VSV) infection (PubMed : 17709747). Required for the translation of incoming hepatitis C virus (HCV) RNA and, thereby, for initiation of HCV replication, but not required once infection is established (PubMed : 19666601).
See full target information ATG5

Publications (285)

Recent publications for all applications. Explore the full list and refine your search

Research and reports in urology 17:383-399 PubMed41048480

2025

Influencing Factors and Risk Prediction Model Construction of Urinary Tract Infections in Patients with Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yancheng Di,Lingling Zhang,Linlin Zhao,Lei Yin

Autophagy :1-16 PubMed40851209

2025

LC3 and GABARAP independent autophagy of misfolded procollagen in mouse osteoblasts.

Applications

Unspecified application

Species

Unspecified reactive species

Elena Makareeva,Shakib Omari,Anna M Roberts-Pilgrim,Laura Gorrell,Bella Radant,Muthulakshmi Sellamani,Edward L Mertz,Basma Khoury,Kenneth Kozloff,Sergey Leikin

American journal of cancer research 15:2949-2969 PubMed40814362

2025

Increased autophagy activity suppresses hyperglycemia-related colorectal cancer tumorigenesis both and .

Applications

Unspecified application

Species

Unspecified reactive species

Pei-Wen Lin,Yu-Wen Liu,Man-Ling Chu,Chien-An Chu,Chung-Ta Lee,Yao-Hsiang Shih,Sheng-Hui Lan,Shang-Ying Wu,Hong-Yi Chang,Wei-Chung Chen,I-Chen Wu,Li-Tzong Chen,Ming-Yii Huang,Jaw-Yuan Wang,Ying-Ray Lee,Hsiao-Sheng Liu

Scientific reports 15:29484 PubMed40796594

2025

Cardamonin inhibits the growth and stemness of osteosarcoma stem cells by inducing autophagy and inhibiting the Wnt/β-catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lulu Zhang,Yu Jin,Qiannan Ding,Yulei Li,Lixia Yang,Mengyun Li,Zuo Lv,Kaifang Wang,Maowei Yang,Haixin Zhang,Xiucheng Li

Journal of traditional and complementary medicine 15:434-445 PubMed40677544

2025

Salvianic acid A promotes osteogenic differentiation of bone marrow mesenchymal stem cells in senile osteoporosis through bromodomain-containing protein 4/Ariadne RBR E3 ubiquitin-protein ligase 1/Rubicon axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhixian Xu,Jun Luo,Yongfa Zhang,Zhenyu Zhang,Jie Xu

Acta biochimica et biophysica Sinica : PubMed40567051

2025

Therapeutic potential of targeting the NEDD4L-eEF1A1 axis in cancer therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Qin,Xinyue Wang,Minghui Zhao,Yuehui Liu,Huiyi Hou,Tingting Wang,Yuhe Pei,Jingxin Zhang,Zhou Shen,Feixiang Wu,Lishuang Zheng,Jinghua Li,Zhiyu Ni,Jianhong Shi

Frontiers in oncology 15:1531420 PubMed40519291

2025

Metformin inhibits the proliferation of hepatocellular carcinoma cells through inducing ferroptosis analyzed by phosphoproteomics.

Applications

Unspecified application

Species

Unspecified reactive species

Jihan Sun,Xi Yu,Yuying Shan,Manyun Dai,Andrea Gaucherot,Caide Lu,Shuqi Mao

Nature communications 16:5261 PubMed40480980

2025

TANGO2 binds crystallin alpha B and its loss causes desminopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Maike Stentenbach,Laetitia A Hughes,Samuel V Fagan,Blake Payne,Danielle L Rudler,Stefan J Siira,Tim McCubbin,Anaëlle Chopin,Kara L Perks,Judith A Ermer,James Hendry,Teagan S Er,Shanti Balasubramaniam,Joel A Eliades,Livia C Hool,Nicolle H Packer,Edward S X Moh,Benjamin S Padman,Oliver Rackham,Aleksandra Filipovska

Discover oncology 16:687 PubMed40338396

2025

Inhibition of ATG5-mediated autophagy maintains PMAIP1 stability to promote cell apoptosis and suppress triple-negative breast cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Fangjian Shang,Hongfeng Nie,Liyan Du,Jin Shang,Xiangquan Song,Ya Chen,Hui Li,Zhuo Wang,Yixin Qi,Liyan Zhao

Scientific reports 15:15572 PubMed40320451

2025

Unveiling the protective role of ESM1 in endothelial cell proliferation and lipid reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Yukun Li,Anbo Gao,Wenchao Zhou,Xing Tang,Tian Zeng,Tingyu Fan,Weimin Jiang,Min Tang,Fan Ouyang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com